Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Special Issue Article - Biomedical Research (2017) Volume 0, Issue 0

Immunohistochemical screening for ALK fusion gene in signet-ring cell gastric carcinoma

The aim of this study was to prescreen the expression of ALK-positive in signet-ring cell gastric carcinoma by IHC assay. We selected 84 FFPE samples with signet-ring cell gastric carcinoma (55 cases of GC, 29 cases of EGJ) and performed the detection of ALK-positive using IHC. The correlation of ALK-positive and clinicopathologic characteristics was statistically analyzed. The results showed, of 84 cases prescreened, 11 (13.09%) were ALK-positive. For the 6 cases with IHC 2+ (7.14%), and the 5 cases with IHC 1+ (5.95%). We noted that 8 (72.73%) cases were never smoker, 8 (72.73%) cases were >5 cm tumor size and 9 (81.82%) cases were T4 in invasive depth. All of the 11 cases were III of pathologic TNM stage. The ALK-positive patients showed significantly statistical difference in lymph node metastasis (p=0.0285) and TNM stage (p=0.0497), compared with the ALK-negative patients. In conclusion, the expression of ALK fusion is found in signet-ring cell gastric carcinoma by IHC assay.

Author(s): Liang Chang, Bingjie Huo, Yalei Lv, Yujie Shan, Wei Liu

Abstract Full Text PDF

Get the App